Intestinal ultrasound in ulcerative colitis – an objective biomarker for treatment response?

The use of transabdominal intestinal ultrasound (IUS) as an objective biomarker of inflammation in ulcerative colitis (UC) is gaining acceptance [1]. IUS ability to correctly identify inflammation and extent of inflammation has been explained in several studies [2]. The advantages over endoscopy or other cross-sectional modalities are many; IUS is a non-invasive, preparation – and radiation-free, easily repeated and patient friendly modality [1]. When visualizing disease burden in real-time, clinicians can better explain and motivate treatment decisions, helping patients to understand their disease [3].

Publikationsverlauf

Artikel online veröffentlicht:
03. August 2021

• References

• 1 Bryant RV, Friedman AB, Wright EK. et al. Gastrointestinal ultrasound in inflammatory bowel disease: An underused resource with potential paradigm-changing application. Gut 2018; 973-985
• 2 Smith RL, Taylor KM, Friedman AB. et al. Systematic Review: Clinical Utility of Gastrointestinal Ultrasound in the Diagnosis, Assessment and Management of Patients With Ulcerative Colitis. J Crohn’s Colitis 2020; 14: 465-479
• 3 Rajagopalan A, Sathananthan D, An YK. et al. Gastrointestinal ultrasound in inflammatory bowel disease care: Patient perceptions and impact on disease-related knowledge. JGH Open 2020; 4: 267-272
• 4 Maaser C, Petersen F, Helwig U. et al. Intestinal ultrasound for monitoring therapeutic response in patients with ulcerative colitis: Results from the TRUST&UC study. Gut 2020; 69: 1629-1636
• 5 Smith RL, Taylor KM, Friedman AB. et al. Early Assessment With Gastrointestinal Ultrasound in Patients Hospitalised for a Flare of Ulcerative Colitis and Predicting the Need for Salvage Therapy: A Pilot Study. Ultrasound Med Biol 2021; 47: 1108-1114
• 6 Grant RK, Jones GR, Plevris N. et al. The ACE (Albumin, CRP and Endoscopy) Index in Acute Colitis: A Simple Clinical Index on Admission that Predicts Outcome in Patients With Acute Ulcerative Colitis. Inflamm Bowel Dis 2021; 27: 451-457
• 7 Lynch RW, Lowe D, Protheroe A. et al. Outcomes of rescue therapy in acute severe ulcerative colitis: data from the United Kingdom inflammatory bowel disease audit. Aliment Pharmacol Ther 2013; 38: 935-945